According to a recent report from Atlanta-area news outlet 11Alive, The Drug Enforcement Administration (DEA) last month sent letters to pharmacies in Georgia telling them that selling medical cannabis products – in line with state law – runs counter to federal law.
“All DEA registrants, including DEA registered pharmacies are required to abide by all relevant federal laws and regulations. A DEA-registered pharmacy may only dispense controlled substances in Schedules II-V of the Controlled Substances Act. Neither marijuana nor THC can be lawfully possessed, handled, or dispensed by any DEA-registered pharmacy. Under federal law, products derived from the cannabis plant with delta-9 THC content above 0.3% are considered marijuana, a Schedule I controlled substance. Further, products that contain any amount of a synthetically produced THC are considered tetrahydrocannabinols, likewise a Schedule I controlled substance.”
DEA Diversion Control Division letter via 11Alive
Some pharmacies in Georgia started dispensing low-THC cannabis oils in October under a first-in-the-nation state law.
Ira Katz of Little Five Points Pharmacy, who received a DEA letter, said the DEA policy “doesn’t make any sense … that people can go to a dispensary and not to a